ITCI Intra-Cellular Therapies: Narxning prognoz qilingan daromadga nisbati
Forward P/S koeffitsiyenti Intra-Cellular Therapies (ITCI) kompaniyasining baholash dinamikasini aks ettiradi. O'sish tremor bilan bog'liq nojo'ya ta'sirlardan xoli bo'lgan noyob shizofreniya davolash vositasi CAPLYTA muvaffaqiyati bilan ta'minlanmoqda. 20.60 ko'rsatkichi kompaniya ushbu dori vositasining depressiyani davolashdagi qo'llanilishini kengaytirayotgan bir paytda joriy darajalarni tasdiqlaydi. Bardoshli pul oqimi va kuchli bozor impulsi barqaror marjalarni hamda ishonchli o'sish trayektoriyasini ta'minlaydi.
intracellulartherapies.com (ITCI) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning xususiy kapitalga nisbati Intra-Cellular Therapies|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Intra-Cellular Therapies, Inc.|ITCI - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Intra-Cellular Therapies, Inc.|ITCI - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Intra-Cellular Therapies|Tezkor likvidlik ko‘rsatkichi intracellulartherapies.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ITCI - Soliqlar to‘langandan keyingi foyda|Prognoz qilingan kelajakdagi foyda Intra-Cellular Therapies|ITCI - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Intra-Cellular Therapies, Inc.|ITCI - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Intra-Cellular Therapies, Inc.|ITCI - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) Intra-Cellular Therapies|ITCI - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi intracellulartherapies.com|ITCI - Joriy yilda bir aksiya uchun foyda dinamikasi|Keyingi yil uchun foyda o'sishi prognozi Intra-Cellular Therapies
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning fundamental tahlili:ITCI (Intra-Cellular)
Klinikalar bilan hamkorlik orqali Caplyta tijoratlashtirish samaradorligi Intra-Cellular Therapies (ITCI) uchun prognoz qilingan bozor kapitalizatsiyasining daromadga nisbati ko'rsatkichiga bevosita ta'sir qiladi. Ushbu ko'rsatkich Intra-Cellular Therapies (ITCI) ning joriy bozor qiymatini prognoz qilingan 10-K/10-Q moliyaviy ma'lumotlari bilan solishtiradi, bu esa investorlarga kutilayotgan savdolarga nisbatan baholashning adolatli ekanligini real vaqt rejimida baholash hamda haddan tashqari to'lov yoki biznesning past baholanishi xatarlarini zudlik bilan aniqlash imkonini beradi.
Muhim raqobatchilar
Forvard P/S multiplikatori BIIB (Biogen)|Neurocrine (NBIX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|RGC - Narxning prognoz qilingan daromadga nisbati|AXSM: Narxning prognoz qilingan daromadga nisbati|ACADIA Pharmaceuticals (ACAD) - Narxning prognoz qilingan daromadga nisbati|XENE (xenon-pharma.com) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori VKTX|Forvard P/S multiplikatori Supernus Pharmaceuticals, Inc.|Narxning prognoz qilingan daromadga nisbati Catalyst Pharmaceuticals Inc (CPRX)|Narxning prognoz qilingan daromadga nisbati DNLI (Denali Corp)|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|Forvard P/S multiplikatori biohavenpharma.com BHVN|AMLX - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx TRVI (Trevi Therapeutics Inc)|PRAX (Praxis Medicines) - Forvard narx/daromad multiplikatori|Anavex Life Sciences Corp - Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori CBLL|PRTA (Prothena Corporation) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori ALEC|ANNX (Annexon Biosciences) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori OMER (Omeros)|Neurogene Therapeutics (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ACIU - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx VYGR (voyagertherapeutics.com)|NMRA: Forvard P/S multiplikatori|Scilex Holding (SCLX) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Tevogen Bio Holdings, Inc.|Alpha Cognition Corp - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori CGTX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati inhibikase.com|Forvard P/S multiplikatori SAVA (Cassava Sciences)|Assertio Holdings (ASRT) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|COYA - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Vistagen Therapeutics VTGN|OVID: Forvard P/S multiplikatori|ABOS - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori CRVO|ATHE (Alterity Therapeutics Ltd) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori CLNN|Forvard narx/daromad multiplikatori pepgen.com PEPG|Forvard P/S multiplikatori JUNS (Jupiter Neurosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati relmada.com (RLMD)|ANVS - Narxning prognoz qilingan daromadga nisbati|GRCE (Grace Therapeutics, Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|AIFF: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Klotho Neurosciences (KLTO)|Forvard narx/daromad multiplikatori NRSN|Forvard P/S multiplikatori revivapharma.com|Narxning prognoz qilingan daromadga nisbati MetaVia Inc (MTVA)|NRXS (NeurAxis Inc.) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Helius Medical Technologies HSDT|Passage Bio Inc. (PASG) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Neuphoria - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati minervaneurosciences.com NERV|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ADXN|Forvard narx/daromad multiplikatori ALZN|CYCN (Cyclerion) - Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CRGT (Cortigent)|Forvard P/S multiplikatori Avenue Therapeutics Inc. ATXI|BCLI: Forvard narx/daromad multiplikatori|Prognoz narxning daromadga nisbati Cara Therapeutics Inc (CARA)|CHRO: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Eliem Therapeutics Inc.|LBPH (Longboard Pharmaceuticals, Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Marinus Pharmaceuticals Inc MRNS|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|Narxning prognoz qilingan daromadga nisbati NRBO (NeuroBo Pharma)|Narxning prognoz qilingan daromadga nisbati Sage Therapeutics, Inc. SAGE|synaptogen.com - Narxning prognoz qilingan daromadga nisbati|TRVN: Forvard narx/daromad multiplikatori|VIGL - Forvard P/S multiplikatori|Anew Medical (WENA) - Narxning prognoz qilingan daromadga nisbati|CERE (Cerevel Corp) - Narxning prognoz qilingan daromadga nisbati
